ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,266Medicare Part D Prescriptions Filled, Including Refills

Rank: 130 out of 1006

$682K Total Retail Price of All Prescriptions

Rank: 109 out of 1006

528 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 528 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 528 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,457 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 595 562 1 1
LEVOTHYROXINE SODIUM 387 346 2 2
FUROSEMIDE 325 284 3 6
LISINOPRIL 324 294 4 3
METOPROLOL TARTRATE 259 254 5 7
AMLODIPINE BESYLATE 228 210 6 4
OMEPRAZOLE 214 168 7 9
ATORVASTATIN CALCIUM 200 188 8 5
ATENOLOL 162 133 9 13
ESCITALOPRAM OXALATE 160 140 10 27
ZOLPIDEM TARTRATE 128 110 11 14
NEXIUM 121 97 12 28
DIOVAN 118 104 13 16
METOPROLOL SUCCINATE 117 108 14 12
WARFARIN SODIUM 116 114 15 8
AZITHROMYCIN 109 91 16 39
HYDROCODONE-ACETAMINOPHEN 108 104 S3 17 25
KLOR-CON M20 107 97 18 70
PREDNISONE 105 100 19 33
DONEPEZIL HCL 105 105 19 17
SERTRALINE HCL 98 90 21 19
CRESTOR 98 95 21 18
METFORMIN HCL 92 82 23 10
DIOVAN HCT 86 71 24 60
CIPROFLOXACIN HCL 85 79 25 75
BENICAR 81 80 26 78
CLOPIDOGREL 81 81 26 46
AMLODIPINE BESYLATE-BENAZEPRIL 80 78 28 77
ACETAMINOPHEN-CODEINE 76 49 S3 29 139
PANTOPRAZOLE SODIUM 74 69 30 32
SYNTHROID 73 69 31 42
TAMSULOSIN HCL 70 68 32 23
NAPROXEN 70 53 32 121
HYDROCHLOROTHIAZIDE 68 63 34 11
BENICAR HCT 67 66 35 120
CARBIDOPA-LEVODOPA 66 63 36 80
PRAVASTATIN SODIUM 66 64 36 15
TRIAMTERENE-HCTZ 63 63 38 58
TRAZODONE HCL 61 59 39 21
POTASSIUM CHLORIDE 57 53 40 30
GLIPIZIDE 57 57 40 69
CITALOPRAM HBR 56 50 42 24
LIPITOR 55 51 43 47
ALENDRONATE SODIUM 53 48 44 29
SPIRIVA 51 51 45 48
PLAVIX 50 50 46 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.